ALDVI.PA
Advicenne SA
Price:  
1.66 
EUR
Volume:  
23,152.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALDVI.PA EV/EBITDA

-272.8%
Upside

As of 2025-11-13, the EV/EBITDA ratio of Advicenne SA (ALDVI.PA) is -14.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALDVI.PA's latest enterprise value is 41.62 mil EUR. ALDVI.PA's TTM EBITDA according to its financial statements is -2.88 mil EUR. Dividing these 2 quantities gives us the above ALDVI.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.1x - 6.2x 4.6x
Forward P/E multiples 10.6x - 11.5x 11.0x
Fair Price (3.42) - (2.53) (2.86)
Upside -306.5% - -252.6% -272.8%
1.66 EUR
Stock Price
(2.86) EUR
Fair Price

ALDVI.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-11-07 -14.33
2025-11-06 -14.73
2025-11-05 -14.69
2025-11-04 -14.79
2025-11-03 -14.67
2025-10-31 -14.38
2025-10-30 -14.41
2025-10-29 -14.50
2025-10-28 -15.00
2025-10-27 -14.41
2025-10-24 -14.27
2025-10-23 -14.39
2025-10-22 -14.51
2025-10-21 -14.74
2025-10-20 -14.65
2025-10-17 -14.77
2025-10-16 -14.83
2025-10-15 -15.15
2025-10-14 -15.05
2025-10-13 -14.26
2025-10-10 -14.58
2025-10-09 -14.97
2025-10-08 -14.66
2025-10-07 -14.22
2025-10-06 -14.60
2025-10-03 -14.71
2025-10-02 -14.86
2025-10-01 -14.99
2025-09-30 -14.39
2025-09-29 -13.68
2025-09-26 -14.05
2025-09-25 -14.79
2025-09-24 -15.23
2025-09-23 -14.12
2025-09-22 -12.59
2025-09-19 -12.54
2025-09-18 -12.61
2025-09-17 -12.64
2025-09-16 -12.83
2025-09-15 -13.03
2025-09-12 -12.67
2025-09-11 -12.63
2025-09-10 -12.62
2025-09-09 -12.75
2025-09-08 -12.50
2025-09-05 -12.59
2025-09-04 -12.45
2025-09-03 -12.39
2025-09-02 -12.53
2025-09-01 -12.55